Appendix H
Committee Biographies

Claire V. Broome, M.D. (Chair), is currently an adjunct professor in the Department of Global Health at the Rollins School of Public Health, Emory University. Previously she held several positions at the Centers for Disease Control and Prevention (CDC) including senior adviser, Integrated Health Information Systems (2000-2006); deputy director (1994-1999); acting director (1998); acting director, National Center for Injury Prevention and Control (1991-1993); associate director for science (1990-1994); and chief, Bacterial Special Pathogens Branch, National Center for Infectious Diseases (1981-1990). Dr. Broome has served as an adviser for the following institutions: World Health Organization; World Bank; Global Alliance for Vaccines and Immunization; The Bill & Melinda Gates Foundation; Burroughs Wellcome Fund; the Wellcome Trust; U.S. Agency for International Development (USAID); the U.S. Food and Drug Administration (FDA) (member, Vaccines and Related Biologicals Advisory Committee); and the National Institutes of Health (NIH). Dr. Broome’s research experience includes developing and implementing research programs in bacterial disease epidemiology, observational epidemiology for vaccine evaluation, and public health surveillance methodology. She also has informatics experience, including leading the development and implementation of the National Electronic Disease Surveillance System. Dr. Broome has received numerous honors and awards including Infectious Disease Society of America’s Squibb Award for Excellence of Achievement in Infectious Diseases; American Public Health Association Epidemiology Section’s John Snow Award; U.S. Public Health Service (PHS) Distinguished Service Medal; Surgeon General’s Medallion; Charles Shepard Award 1986; and Langmuir award

Citation Manager

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 349
Appendix H
Committee Biographies
Claire V. Broome, M.D. (Chair), is currently an adjunct professor in the
Department of Global Health at the Rollins School of Public Health, Emory
University. Previously she held several positions at the Centers for Disease
Control and Prevention (CDC) including senior adviser, Integrated Health
Information Systems (2000-2006); deputy director (1994-1999); acting
director (1998); acting director, National Center for Injury Prevention
and Control (1991-1993); associate director for science (1990-1994); and
chief, Bacterial Special Pathogens Branch, National Center for Infectious
Diseases (1981-1990). Dr. Broome has served as an adviser for the follow-
ing institutions: World Health Organization; World Bank; Global Alliance
for Vaccines and Immunization; The Bill & Melinda Gates Foundation;
Burroughs Wellcome Fund; the Wellcome Trust; U.S. Agency for Inter-
national Development (USAID); the U.S. Food and Drug Administration
(FDA) (member, Vaccines and Related Biologicals Advisory Committee);
and the National Institutes of Health (NIH). Dr. Broome’s research experi-
ence includes developing and implementing research programs in bacterial
disease epidemiology, observational epidemiology for vaccine evaluation,
and public health surveillance methodology. She also has informatics experi-
ence, including leading the development and implementation of the National
Electronic Disease Surveillance System. Dr. Broome has received numer-
ous honors and awards including Infectious Disease Society of America’s
Squibb Award for Excellence of Achievement in Infectious Diseases; Ameri-
can Public Health Association Epidemiology Section’s John Snow Award;
U.S. Public Health Service (PHS) Distinguished Service Medal; Surgeon
General’s Medallion; Charles Shepard Award 1986; and Langmuir award

OCR for page 349
0 PRIORITIES FOR THE NATIONAL VACCINE PLAN
coauthor in 1981, 1983, 1988, 1989, 1993; she is a member of the Institute
of Medicine. Dr. Broome received her B.A. from Harvard University and her
M.D. from Harvard Medical School; she specialized in internal medicine
at the University of California, San Francisco. She was a CDC Epidemic
Intelligence Service (EIS) officer and completed a fellowship in infectious
diseases at Massachusetts General Hospital.
Élaine Chatigny is director general, Communications, at the Public Health
Agency of Canada. She is responsible for risk communications, crisis com-
munications, strategic communication planning, media relations, social
marketing, and a host of other communication functions. Her previous
position with the government of Canada was director, Public Affairs, with
the Communications, Marketing, and Consultation Directorate at Health
Canada. In her 8 years with the government of Canada, Ms. Chatigny
has established Crisis and Emergency Communications and Risk Com-
munications Units. She was also responsible for the development of Health
Canada’s and the Public Health Agency of Canada’s Risk Communications
Framework and Handbook, which is unique to the government of Canada.
Ms. Chatigny has been an external adviser to the World Health Organiza-
tion on pandemic influenza communications planning and co-chair of the
Communicators’ Network of the Global Health Security Initiative (G7 plus
Mexico); she is the founder of a federal, provincial, and territorial commu-
nications working group on pandemic influenza, which reports to Canada’s
Pandemic Influenza Committee. Prior to joining the federal government,
Ms. Chatigny worked 14 years with the Canadian Broadcasting Corpora-
tion as a journalist and a manager.
Jocelyn Guyer, M.P.A., is co-executive director at the Center for Children
and Families (CCF) and a senior researcher at the Georgetown University
Health Policy Institute. At CCF, she has worked extensively on child and
family health issues, including reauthorization of the State Children’s Health
Insurance Program (SCHIP) and the role of Medicaid in covering children
and families. She joined CCF from the Kaiser Commission on Medicaid and
the Uninsured, where she served most recently as an associate director. At
the commission, she led analysis of several emerging issues in health care
for vulnerable Americans, including the implications of the Part D Medicare
drug benefit for impoverished seniors and people with disabilities, and major
proposals to restructure Medicaid. In the past, she has served as a senior
health policy analyst on health and welfare policy at the Center on Budget
and Policy Priorities, where she designed policy initiatives to expand cover-
age to low-income parents and worked with several states to implement
family-based coverage expansions. She also served as legislative research
assistant to Senator Daniel Patrick Moynihan. She holds an M.P.A. in

OCR for page 349
APPENDIX H
economics and public policy from Princeton University’s Woodrow Wilson
School and a B.A. in political science from Brown University.
Timothy J. Hoff, Ph.D., is associate professor of health policy and manage-
ment in the Department of Health Policy, Management, and Behavior at
the Statte University of New York (SUNY) at Albany. Dr. Hoff received his
B.S. in business administration from SUNY Albany and his Ph.D. in public
administration and policy from the Rockefeller College of Public Affairs
and Policy. His areas of expertise include strategic planning and evaluation,
health care policy, medical sociology, primary care delivery, organization
theory and behavior, organizational change and innovation, organizational
design, and public health genomics. Dr. Hoff’s current research focuses on
the evolution of primary care medicine, newborn screening policy in the
United States, and the redesign of healthcare delivery settings for more ef-
fective chronic disease management. Recently, he was engaged in patient
safety research examining the role of organizational culture in creating
safer clinical environments. He also has completed a national study of state
newborn screening programs and issues related to long-term follow-up of
newborns identified with genetic and metabolic disorders. This research is
unique nationally and is adding to our understanding of quality and access
issues in the area of newborn screening. He was the chair of the Health
Care Management Division of the Academy of Management, the leading
academic organization in the United States for management scholars, and a
two-time winner of the SUNY Albany School of Public Health’s Excellence
in Teaching Award.
Grace M. Lee, M.D., M.P.H., is an assistant professor of population medi-
cine and pediatrics at the Harvard Medical School, Harvard Pilgrim Health
Care Institute, and Children’s Hospital Boston. Dr. Lee’s research focuses
on vaccine economics, vaccine safety, infectious disease epidemiology, and
infection control and prevention. She is currently principal investigator or
coinvestigator on Agency for Healthcare Research and Quality (AHRQ)-,
NIH-, and CDC-funded studies. Several key research projects include con-
ducting active surveillance of H1N1 and seasonal influenza vaccine safety in
the United States, understanding gaps in the vaccine financing and delivery
system, modeling the cost-effectiveness of vaccines and interventions to
reduce health care–associated infections, and evaluating the impact of
Medicare’s policy of nonpayment for health care–associated infections in
hospital settings. Dr. Lee joined the faculty at Harvard Medical School,
Harvard Pilgrim Health Care Institute, and Children’s Hospital Boston in
2003 after completing an AHRQ postdoctoral fellowship. She received her
M.D. at the University of Pennsylvania School of Medicine and M.P.H. at
Harvard School of Public Health. She completed her pediatric residency and

OCR for page 349
PRIORITIES FOR THE NATIONAL VACCINE PLAN
subspecialty training in pediatric infectious diseases and pediatric health
services research at Children’s Hospital Boston.
Richard Mandsager, M.D., is chief executive at Providence Alaska Medi-
cal Center and was the executive director of the Children’s Hospital at
Providence in Anchorage from October 2006 to August 2009. From 2004
to 2006, he was the director of public health for the State of Alaska. Dur-
ing his tenure, legislative support and funding were achieved for purchase,
implementation, and operation of an immunization registry. Prior to that,
he was medical director of the Pediatric Service Center of Alaska Native
Medical Center (ANMC) in Anchorage. While he was in that position the
ANMC achieved more than a 90 percent immunization rate for children.
His prior experience includes serving as staff pediatrician for Southcentral
Foundation, where he revised and improved protocols for medical care for
children and adolescents. Dr. Mandsager has also served as the past direc-
tor for the Alaska Native Medical Center and service unit director for the
Anchorage Service Unit. He led and facilitated completion of the ANMC
hospital campus, which was the largest project in the history of the Indian
Health Service and the first joint construction project of the Indian Health
Service and the Centers for Disease Control and Prevention in Atlanta. He
retired from the Commissioned Corps of the U.S. Public Health Service with
the rank of an assistant surgeon general.
Edgar K. Marcuse, M.D., M.P.H., is a professor of pediatrics and adjunct
professor of epidemiology at the University of Washington Schools of
Medicine and Public Health and associate medical director for quality
improvement at Seattle Children’s. Dr. Marcuse has been actively involved
with numerous pediatric and public health organization immunization ac-
tivities at the local, regional, and national levels. Nationally, he served as
member and chair of the U.S. Department of Health and Human Service’s
(HHS’s) National Vaccine Advisory Committee, a member of the Advisory
Committee on Immunization Practices, a member of the American Acad-
emy of Pediatrics (AAP) Committee on Infectious Disease (Red Book),
an associate editor and consultant for several editions of the Red Book,
and chair of the AAP Immunization Advisory Team. He is coeditor of
AAP Grand Rounds. Dr. Marcuse received his B.A. from Oberlin Col-
lege in Ohio, his M.D. from Stanford University School of Medicine,
his M.P.H. from the University of Washington School of Public Health
and Community Medicine, and his pediatric training at Children’s Hos-
pital, Boston and Seattle Children’s, and he served as a CDC EIS officer.
A. David Paltiel, Ph.D., is professor of public health and managerial sciences
at the Yale School of Medicine. He also holds an appointment as profes-

OCR for page 349
APPENDIX H
sor at the Yale School of Management. His research deals broadly with
issues of resource allocation and decision making in health and medicine. An
expert in the application of mathematical and economic simulation models
to inform public choice and clinical practice, he has conducted model-
based cost-effectiveness analyses and policy evaluations on such subjects
as expanded screening for HIV, inhaled steroids in adult asthma, treatment
options for patients with knee pain and osteoarthritis, and the FDA’s ap-
proval of home testing for HIV. He is an officer of the Society for Medical
Decision Making and a member of the Scientific Review Committee of the
French National Agency for Research on AIDS and Viral Hepatitis. He has
previously served on the editorial boards of both Medical Decision Making
and Value in Health. Dr. Paltiel received his Ph.D. in operations research
from Yale in 1992.
Arthur L. Reingold, M.D., is professor of epidemiology and associate dean
for research of the University of California at Berkeley (UCB) School of
Public Health. He is also professor of epidemiology and biostatistics and
clinical professor of medicine at the University of California, San Francisco
(UCSF). His research interests include emerging and reemerging infections
and vaccine-preventable diseases in the United States and developing coun-
tries. Dr. Reingold currently serves on the World Health Organization’s Stra-
tegic Advisory Group of Experts on vaccines and vaccine policy; is director
of the California Emerging Infections Program; and is director of the NIH
Fogarty AIDS International Training and Research Program at UCB-UCSF.
Recent publications include articles on the impact of the introduction of
pneumococcal conjugate vaccine in the United States and related topics.
Before joining the faculty at UCB, Dr. Reingold worked for eight years at
CDC. He was elected to the Institute of Medicine (IOM) in 2003.
David B. Reuben, M.D., is director, Multicampus Program in Geriatrics
Medicine and Gerontology (MPGMG), and chief, Division of Geriatrics, at
the University of California at Los Angeles (UCLA) Center for Health Sci-
ences. He is the Archstone Foundation Chair and Professor at the David
Geffen School of Medicine at UCLA. He is also director of the UCLA Claude
D. Pepper Older Americans Independence Center. Dr. Reuben sustains
professional interests in clinical care, education, research, and administra-
tive aspects of geriatrics. He maintains a clinical primary care practice of
frail older persons and attends on inpatient and geriatric psychiatry units at
UCLA. He has won seven awards for excellence in teaching. Dr. Reuben’s
current research interests include redesigning the office visit to improve
healthcare quality and measurement of how older adults function. In 2000,
Dr. Reuben was given the Dennis H. Jahnigen Memorial Award for out-
standing contributions to education in the field of geriatrics, and in 2008,

OCR for page 349
PRIORITIES FOR THE NATIONAL VACCINE PLAN
he received the Joseph T. Freeman Award from the Gerontological Society
of America. Dr. Reuben was part of the team that received the 2008 John
M. Eisenberg Patient Safety and Quality Award for Research—Joint Com-
mission and National Quality Forum, for Assessing Care of the Vulnerable
Elderly (ACOVE). He is a past president of the American Geriatrics Soci-
ety and the Association of Directors of Geriatric Academic Programs. Dr.
Reuben is currently chair-elect of the Board of Directors of the American
Board of Internal Medicine and sits on its Executive Committee. He is lead
author of the widely distributed book Geriatrics at Your Fingertips. Dr.
Reuben produced Freda Sandrich: Center Stage, a short documentary that
was a finalist for a FREDDIE award. His play about decision making at the
end of life, Repriees, had its first reading in Los Angeles in 2007 and has
had two subsequent commissioned readings, by the California Healthcare
Foundation in 2008 and by the Friends of the Semel Institute in 2009. His
second play is about Lyndon Johnson and the Civil Rights Act of 1957. Dr.
Reuben has served on four past IOM committees.
Sara Rosenbaum, J.D., is chair of the Department of Health Policy and
Harold and Jane Hirsh Professor of Health Law and Policy at the George
Washington University. She also holds an appointment as professor of
health care sciences at George Washington’s School of Medicine and Law.
As a scholar, an educator, and a national leader, Professor Rosenbaum has
dedicated her career to promoting more equitable and effective health care
policies in this country, particularly in the areas of Medicaid and Medicare,
managed care, employee health benefits, maternal and child health, health
services for medically underserved populations, and civil rights in health care
systems. Her commitment to strengthening access to care for low-income,
minority, and medically underserved populations has had a transforming
effect on the lives of many Americans, particularly children. In addition to
her responsibilities as chair of the Department of Health Policy, which she
founded and developed, Professor Rosenbaum directs the Hirsh Health Law
and Policy Program. As a mentor, she is drawn to young people interested in
improving health care for the poor. Professor Rosenbaum has been named
one of the nation’s 500 most influential health policy makers by McGraw
Hill. Among other honors, she has received the Investigator Award in Health
Policy from the Robert Wood Johnson Foundation and has been recognized
by the Department of Health and Human Services for distinguished national
service on behalf of Medicaid beneficiaries. As a member of the White House
Domestic Policy Council under President Clinton, she directed the drafting
of the Health Security Act and oversaw the development of the Vaccines for
Children Program. Professor Rosenbaum received her B.A. from Wesleyan
University and her J.D. from Boston University School of Law.

OCR for page 349
APPENDIX H
Milagritos D. Tapia, M.D., is assistant professor of pediatrics and medicine
at the University of Maryland. She is interested in the utility of oral fluid as
a proxy for serum measurement of antibody responses. She has found that
there is an excellent correlation between the serum and oral fluid measure-
ments of antibodies against measles, meningococcus, and tetanus. She also
spends a great deal of her time working at the Center for Vaccine Develop-
ment field site in Bamako, Mali, in West Africa. There, she has been studying
the epidemiology of invasive bacterial infections, the incidence of group A
streptococcal pharyngitis, and the prevalence of rheumatic heart disease in
the pediatric population. She was coinvestigator on several multicenter vac-
cine trials including an efficacy trial of rotavirus vaccine in Malian infants
and safety and immunogenicity trials of conjugate meningococcal A vaccine
in Malian toddlers and adults.